WuXi Biologics
WXXWY
$11.67
Share price
-6.59%
Change (1 day)
94.99%
Change (1 year)
Categories
Revenue for WuXi Biologics (WXXWY)
Revenue in 2023: NZ$4.22 Billion
According to WuXi Biologics's latest financial reports the company's current revenue (TTM 
) is NZ$4.22 Billion. In 2023 the company made a revenue of NZ$4.22 Billion an increase over the revenue in the year 2022 that were of NZ$3.87 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for WuXi Biologics from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | NZ$4.22 B | 8.85% |
| 2022 | NZ$3.87 B | 37.09% |
| 2021 | NZ$2.82 B | 87.66% |
| 2020 | NZ$1.50 B | 50.9% |
| 2019 | NZ$0.99 B | 54.74% |
| 2018 | NZ$0.64 B | 48.1% |
| 2017 | NZ$0.43 B | 74.7% |
| 2016 | NZ$0.24 B | 65.72% |
| 2015 | NZ$0.15 B | 60.37% |
| 2014 | NZ$93.87 M |